APA

Teishima J., Ohara S., Shinmei S., Inoue S., Hayashi T., Mochizuki H., Mita K., Shigeta M. & Matsubara A. (20181106). Normalization of C-reactive protein levels following cytoreductive nephrectomy in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors is associated with improved overall survival. : Urologic oncology.

Chicago

Teishima Jun, Ohara Shinya, Shinmei Shunsuke, Inoue Shogo, Hayashi Tetsutaro, Mochizuki Hideki, Mita Koji, Shigeta Masanobu and Matsubara Akio. 20181106. Normalization of C-reactive protein levels following cytoreductive nephrectomy in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors is associated with improved overall survival. : Urologic oncology.

Harvard

Teishima J., Ohara S., Shinmei S., Inoue S., Hayashi T., Mochizuki H., Mita K., Shigeta M. and Matsubara A. (20181106). Normalization of C-reactive protein levels following cytoreductive nephrectomy in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors is associated with improved overall survival. : Urologic oncology.

MLA

Teishima Jun, Ohara Shinya, Shinmei Shunsuke, Inoue Shogo, Hayashi Tetsutaro, Mochizuki Hideki, Mita Koji, Shigeta Masanobu and Matsubara Akio. Normalization of C-reactive protein levels following cytoreductive nephrectomy in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors is associated with improved overall survival. : Urologic oncology. 20181106.